Real-time enrollment status for this adhd clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04781140 |
| Recruiting Status | Recruiting |
| Condition | ADHD |
| Phase | Clinical Trial |
| Target Enrollment | 286 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Supernus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04781140 is currently recruiting participants. This clinical trial study for adhd is actively seeking new participants at 47 locations across the United States. The study is sponsored by Supernus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04781140 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04781140 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.